EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species

Anaïs Potron iD, Marion Daniel, Mila Bay, Pauline Choulet, Thomas Garrigos iD, Loïk Sababadichetty, Olivier Belmonte, Damien Fournier, Katy Jeannot, Guillaume Miltgen iD

Microbiology Spectrum · 03.10.2024 · 12 (10)

DOI: 10.1128/spectrum.01044-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.10.2024. Verfasst von Anaïs Potron und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Associé au Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, Besançon, Franc…. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Acinetobacter Infections, Blood Culture. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Acinetobacter baumannii (CRAB) are increasingly reported worldwide and a leading cause of mortality associated with antimicrobial resistance. Their early detection, particularly in the cases of bloodstream infections, is crucial in attempting to initiate effective antibiotic treatment. The immunochromatographic assay RESIST ACINETO (Coris BioConcept) is a new test developed for the detection of OXA-23, OXA-40/58, and New-Delhi Metallo-beta-lactamase (NDM) carbapenemases in Acinetobacter spp. We evaluated this test on a collection of 121 Acinetobacter spp. clinical isolates, including 104 carbapenemase producers (97 carbapenemases targeted by the test) and 17 non-carbapenemase producers. The performance of the RESIST ACINETO test was evaluated according to the manufacturer’s recommendations from bacterial and blood cultures. The strains producing the carbapenemases OXA-23, -40, -58, or/and NDM were accurately detected from bacterial cultures and directly from blood cultures, with the exception of one OXA-23/NDM-1-positive Acinetobacter radioresistens isolate (only detected through standard culture). None of the non-carbapenemase producers tested positive. The RESIST ACINETO test demonstrated sensitivity/specificity of 100%/100% and 99%/100% on bacterial and blood cultures, respectively. IMPORTANCE The incidence of bloodstream infections with carbapenem-resistant Acinetobacter baumannii (CRAB) could be very high in some countries such as the Balkans or Southeast Asia. In case of positive blood cultures with Gram-negative bacteria, the use of the RESIST ACINETO test could prove highly beneficial for the rapid identification of these imipenem-resistant bacteria and their antibiotic resistance mechanisms. In addition, it is now well established that New-Delhi Metallo-beta-lactamase (NDM) carbapenemase-producing isolates can have increased MICs of cefiderocol, which is an alternative treatment for these infections. This test may also allow the optimization of treatment based on the type of carbapenemase present. Finally, the RESIST ACINETO test is a rapid, easy-to-use, and cost-effective assay that demonstrates excellent performance in detecting the major acquired carbapenemases present in the Acinetobacter species .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacterial ProteinsAcinetobacter InfectionsBlood CultureAcinetobacter baumanniiAcinetobacterMicrobial Sensitivity TestsAnti-Bacterial AgentsHumansCarbapenemsSensitivity and Specificity

Stichwörter der Autor:innen

AcinetobacterNDMOXA-23OXA-24/40OXA-58blood culturecarbapenemasesrapid detection

Substanzen

beta-LactamasescarbapenemaseBacterial ProteinsAnti-Bacterial AgentsCarbapenemsbeta-lactamase NDM-1

Autor:innen und Institutionen

  • Laboratoire Associé au Centre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de Besançon, Besançon, France.
  • Université de Franche-Comté, CNRS, UMR 6249 Chrono-environnement, Besançon, France.
  • UMR Processus Infectieux en Milieu Insulaire Tropical, CNRS 9192, INSERM U1187, IRD 249, Université de La Réunion, Saint-Denis, La Réunion, France.
  • Laboratoire de Bactériologie, Centre Hospitalier Universitaire de La Réunion, site Félix Guyon, Saint-Denis, La Réunion, France.
  • Centre Régional en Antibiothérapie de La Réunion (CRAtb Réunion), Saint-Pierre, La Réunion, France.

ORCID-Profile: Anaïs Potron, Thomas Garrigos, Guillaume Miltgen

Zitieren

APA

Potron, A., Daniel, M., Bay, M., Choulet, P., Garrigos, T., Sababadichetty, L., Belmonte, O., Fournier, D., Jeannot, K., & Miltgen, G. (2024). RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species. Microbiology Spectrum, 12(10). https://doi.org/10.1128/spectrum.01044-24

Vancouver

Potron A, Daniel M, Bay M, Choulet P, Garrigos T, Sababadichetty L, et al. RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species. Microbiology Spectrum. 2024;12(10). doi:10.1128/spectrum.01044-24

BibTeX
@article{Potron2024,
  author = {Potron, Anaïs and Daniel, Marion and Bay, Mila and Choulet, Pauline and Garrigos, Thomas and Sababadichetty, Loïk and Belmonte, Olivier and Fournier, Damien and Jeannot, Katy and Miltgen, Guillaume},
  title = {RESIST ACINETO test for the rapid detection of NDM and OXA acquired carbapenemases directly from blood culture in Acinetobacter species},
  journal = {Microbiology Spectrum},
  year = {2024},
  volume = {12},
  number = {10},
  doi = {10.1128/spectrum.01044-24}
}
Kostenlos starten →